Photodynamic therapy of condyloma acuminata in pregnant women
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*Background:* Condyloma acuminatum (CA) is a highly contagious sexually transmitted disease caused by subtypes of the human papilloma virus (HPV). During pregnancy period, patients suffering from CA are generally characterized by fast-growing warts, reduced tolerability and poor compliance to treatment. Topical use of 5-aminolevulinic acid (ALA) in combination with photodynamic therapy has demonstrated a higher clearance rate of warts, lower recurrence rates and a favorable safety profile. It has the advantage of a shortened healing period and less damage to local tissue integrity.

*Methods:* The study composed of five pregnant patients with the complaint of CA was included. Patient 1 was 31-year-old, with cervix and vulva CA at day 38 of gestation. Patient 2 was 32-year-old and at 16 weeks of gestation came with the complaint of perianal verrucous for 2 months. Patient 3 was 32-year-old, presented at 13 weeks of gestation with the complaint of multiple neoplasm in her vagina and cervix. Patient 4 was 31-year-old and presented at 12 weeks of gestation with massive CA warts in the nympha and vagina for 2 weeks. Patient 5 was 25-year-old and at 25 weeks of gestation with CA in vagina.

*Materials and Instruments:* ALA hydrochloride powder for topical use was with specification of 118 mg. An XD2635AB photodynamic laser was used for treatment with emission of the semiconductor laser at a wavelength of 635 nm.

*Efficacy Criteria:* Responses were deemed "complete" if 100% of the lesions disappeared; "partial" in cases of 50-100% clearance; and "poor" when clearance was \< 50%.

*Results:* The clearance rate of genital warts was 100% after four administrations of photodynamic therapy (PDT). The lesions of patient 1 disappeared after three administrations, of patient 2 after one administration with excellent healing, of patient 3 after two administrations, of patient 4 vanished after two administrations and of patient 5 after twice PDT administrations. No severe adverse events were reported. All five pregnancies resulted in healthy live birth without delivery complications.

*Discussion:* Exogenous ALA is selectively absorbed by HPV-infected cells which are highly proliferative and converted into porphyrins such as protoporphyrin IV. PDT is the combination of photosensitizer and semiconductor laser treatment. The size of a normal cervix is 3-4 cm in length and 1-3 cm in diameter, thus PDT has very little chance to directly affect an intrauterine fetus. In addition, the most favorable advantage of PDT is that it abolishes subclinical infection of HPV and decreases recurrence rates of CA from 80-90% to 10%. It is especially effective for CA of the urethral orifice and urethra. Based on our reported five cases, PDT is plausible for CA in pregnancy and is characterized by good tolerance and low recurrence. In summary, PDT-ALA is an efficacious and safe therapeutic option for CA in pregnancy.

Risk factors of the vertical transmission of human papilloma virus in newborns from singleton pregnancy: Preliminary report

Skoczyński M, Goździcka-Józefiak A, Kwaśniewska A. J Matern Fetal Neonatal Med 2013 Jun 21. \[Epub ahead of print\].

*Objective:* The objective of this study was to analyze the relationship between the frequency of human papilloma virus (HPV) isolation in pregnant women and their offspring and to assess the risk of maternal-neonatal transmission.

*Study Design:* The study included vaginal/buccal smears of 135 pregnant women, as well as the buccal smears and the respiratory discharge samples from their neonates. The material was tested for the presence of HPV deoxyribonucleic acid (DNA) by means of polymerase chain reaction.

*Results:* A total of 22 HPV 11-positive cases (16.3%) were detected amongst pregnant women, along with 16 neonatal HPV 11-positive cases (11.85%). The concordance rate of maternal and neonatal HPV 11 DNA was 54.5%. Three maternal variables: The presence of HPV 11, less than 10 years of education and common law proved significant risk factors for vertical transmission.

*Conclusion:* An asymptomatic HPV infection of a pregnant woman rather than the mode of delivery or other obstetrical characteristics constitutes an important risk factor of vertical transmission.

Genotypic prevalence of human papillomavirus infection during normal pregnancy: A cross-sectional study

Kim YH, Park JS, Norwitz ER, Park JW, Kim SM, Lee SM, Park CW, Kim BJ, Koo JN, Oh IH, Song YS. J Obstet Gynaecol Res 2013; doi: 10.1111/jog. 12155. \[Epub ahead of print\].

*Aim:* Genital human papilloma virus (HPV) infection is a necessary factor in most cases of cervical cancer, but malignant transformation requires the presence of additional cofactors such as pregnancy. Little is known about the effect of pregnancy on genital HPV carriage. We therefore analyzed the prevalence and genotypic patterns of genital HPV infections in normal pregnancies.

*Methods:* The prevalence of HPV infection was measured in 960 consecutive normal pregnant or post-partum women by HPV-deoxyribonucleic acid chip analysis of cervical swabs. Data were analyzed by trimester and adjusted for socio-demographic, reproductive and reported sexual history.

*Results:* The overall prevalence of HPV infection in the population was 24.3%. High-risk HPV genotypes were detected in 68.2% of infected subjects, including HPV 16 (18.7%), 39 (16.4%), 53 (10.1%) and 56 (9.4%). High-risk HPV genotypes were significantly more prevalent in the second trimester (23.8%) compared with the other periods (first trimester, 13.2%; third trimester, 17.4%; post-partum, 15.1%; *P* = 0.010). However, the high-risk HPV genotypes 16 or 18 were detected most frequently in the third trimester (7.2%) as compared to the other periods (first trimester, 2.9%; second trimester, 5.2%; post-partum, 2.1%; *P* = 0.03). After adjusting for confounding variables, overall HPV infection (odds ratio = 1.84, 95% confidence interval = 1.24-2.75) and high-risk HPV genotypes (odds ratio = 1.94, 95% confidence interval = 1.23-3.05) were significantly more common in the second trimester.

*Conclusion:* The second trimester may be the most vulnerable period in high-risk HPV infections, which necessitates future investigations.

Human papillomavirus detection in pregnant women: A prospective matched cohort study
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*Objective:* The objective of this study is to determine the prevalence, incidence and clearance of human papillomavirus (HPV) in pregnant and non-pregnant women.

*Methods:* In this prospective matched cohort study, 51 women, became pregnant during follow-up of an HPV epidemiology study (*n* = 2065) and 51 matched non-pregnant women were included. All women provided 3 monthly cervicovaginal self-samples and completed a questionnaire. The polymerase chain reaction SPF (10) LiPA (25) was used for HPV testing. Matching was performed using a propensity score.

*Results:* The cumulative prevalence of high-risk human papilloma virus (hrHPV) was 19.6% (*n* = 10) of the pregnant and 17.6% (*n* = 9) of the matched control women. The time point prevalence of any type HPV and hrHPV was not significantly different for pregnant and matched control women. After baseline, there were 10 newly detected hrHPV types in 6 (11.8%) of the pregnant women and there were 11 newly detected hrHPV types in 8 (15.7%) of the matched control women. There was no difference in HPV clearance between pregnant and matched control women.

*Conclusions:* This study concluded that in a low-parity population of young, unscreened women, pregnancy does not seem to influence HPV prevalence, incidence and clearance.

Rate of vertical transmission of human papillomavirus from mothers to infants: Relationship between infection rate and mode of delivery

Park H, Lee SW, Lee IH, Ryu HM, Cho AR, Kang YS, Hong SR, Kim SS, Seong SJ, Shin SM, Kim TJ. Virol J 2012;9:80.

*Background:* In contrast to the consistent epidemiologic reports, including the role of sexual transmission of human papilloma virus (HPV) in adults, potential routes of HPV infection from mother to newborns were as follows: (1) during passage of the fetus through an infected birth canal, (2) ascending infection after premature rupture of the membranes, (3) infected sperm at fertilization and (4) hematogenous spread. In this study, we have determined the prevalence of HPV infection in pregnant women and the rate of vertical transmission during the perinatal period. The risk factors associated with viral transmission were also explored, including HPV genotypes.

*Results:* A total of 300 term pregnant women were enrolled over the study period. Analyses were restricted to 291 women who gave birth in the institutes through vaginal delivery (*n* = 193, 66.3%) and cesarean section (*n* = 98, 33.7%).

*Maternal HPV Status:* The mean age of pregnant women was 32.8 years and the prevalence of HPV infection was 18.9% (55/291) in maternal cervical swabs at enrolment determined by means of HPV deoxyribonucleic acid (DNA) chips. Prevalence of HPV infection in the newborns was 3.4% (10/291) from swabs of the oral mucosa at delivery. Among the types specified by HPV DNA chip, HPV-16 was the most frequent type in the maternal cervix (*n* = 55), comprising 8 cases (14.5%) and other specified HPV types were as follows: HPV-6, -56 each in 5 cases (9.1%); −53, −58, −70 each in 4 cases (7.3%); -39, -40 each in 3 cases (5.5%); and -44, -51, -31 each in 2 cases (3.6%). Each of HPV-11, -18, -33, -35, -45 and -66 was noted only in one participant. HPV-other type, which was positive in PCR but negative in HPV DNA chip, was noted in 29.1% (16/55). Genotyping showed that 58.2% (32/55) were infected with at least one type of high-risk HPVs. Co-infection with multiple genotypes was noted in 8 mothers; HPV-53 (*n* = 4) was the most frequent type found in multiple infection. Neonatal HPV status: At birth, HPV DNA was detected in 10 (3.4%, 10/291) neonates who were born to HPV-positive mothers. Therefore, the overall frequency of HPV transmission from HPV-positive mothers to their infants was 18.2% (10/55). Genotypes were concordant in all of the mother-neonate pairs. If one type of HPV was identical among multiple types detected in a mother neonate pair, the case was considered to be concordant. HPV-16 and HPV-53 were the most frequent types and each was noted in 2 newborns. Factors associated with vertical transmission: To find out the reproductive characteristics contributing to vertical transmission of HPV, the pairs with HPV-positive mothers were allocated in 2 groups according to HPV status of newborns. All 10 newborns were delivered vaginally.

*Discussion and Conclusions:* The present study has shown the prevalence of HPV infection of the cervix to be 18.9% in 291 Korean pregnant women. Although statistically insignificant, young women under 30 years of age were more infected with HPV. In our study, vertical transmission was found in 18.5% (10/55) with HPV DNA chip, which can identify genotypes even in cases with multiple infections through automated and efficient procedures. In conclusion, the infection and transmission of HPV was prevalent in pregnant women and their neonates. We suggest that the perinatal transmission of HPV takes place through an infected birth canal based on the concordance of HPV genotypes and the predominance of vaginal delivery. However, the clearance of HPV in all infants up to 6 months suggests that HPV DNAs of newborns do not indicate persistent infection in infants.
